EPH63 Exploring the Potential Public Health Benefits of a Respiratory Syncytial Virus (RSV) Vaccine Candidate (Ad26.RSV.preF/RSV) Among Individuals Aged 65 Years and Older in the UK: A Preliminary Mathematical Modelling Approach

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.985
https://www.valueinhealthjournal.com/article/S1098-3015(22)03190-4/fulltext
Title : EPH63 Exploring the Potential Public Health Benefits of a Respiratory Syncytial Virus (RSV) Vaccine Candidate (Ad26.RSV.preF/RSV) Among Individuals Aged 65 Years and Older in the UK: A Preliminary Mathematical Modelling Approach
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03190-4&doi=10.1016/j.jval.2022.09.985
First page :
Section Title :
Open access? : No
Section Order : 10535
Categories :
Tags :
Regions :
ViH Article Tags :